Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are recommended for severe alopecia areata if corticosteroids fail.

Topical cyclosporine lotion led to noticeable hair regrowth in alopecia universalis.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Rituximab may cause skin issues, but baricitinib can help improve them.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

JAK inhibitors show promise for treating alopecia areata but their effectiveness and safety are still debated.

Some drugs used to treat immune conditions may cause different types of hair loss.

Targeted immune modulation can help achieve stable remission in alopecia areata.

Retinoids help treat psoriasis effectively, but they can cause side effects and need more research on safe use with other treatments.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Drug misuse can cause serious eye infections and other severe side effects.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

3D spheroid culture makes stem cells better at reducing inflammation.

Apremilast shows promise for several skin conditions but needs more research.

Topical immunotherapy can help with severe hair loss, but results vary and need personalized, long-term treatment.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Retinol may affect immune responses in people with frequent skin boils.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Managing multiple autoimmune diseases in one patient is very challenging.

JAK inhibitors show promise in treating moderate to severe alopecia areata.

The herbal preparation may help manage alopecia by reducing inflammation and boosting the immune response.